Develops gene therapies for rare skin diseases.
Dec 2025Revenue $5.82M/yrExpenses $95.3M/yr
No trendCash runway ≈ 1.8 years from Jun 2026
Figures by year
When will Abeona Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $5.82M and expenses $95.3M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $5.82M | $95.3M | −$89.4M |
| Dec 2023 | $3.50M | $50.6M | −$47.1M |
| Dec 2022 | $1.41M | $52.3M | −$50.9M |
| Dec 2021 | $3.00M | $92.8M | −$89.8M |
| Dec 2020 | $10.0M | $91.4M | −$81.4M |
| Dec 2018 | $3.00M | $61.2M | −$58.2M |
| Dec 2017 | $837K | $28.7M | −$27.8M |
| Dec 2016 | $889K | $24.8M | −$23.9M |
| Dec 2015 | $1.04M | $19.6M | −$18.5M |
| Dec 2014 | $925K | $4.06M | −$3.13M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.